{"pmid":32480211,"title":"The importance of COVID-19 screening and testing in the obstetric patient population.","text":["The importance of COVID-19 screening and testing in the obstetric patient population.","J Clin Anesth","Hoyler, Marguerite M","Abramovitz, Sharon","Aaronson, Jaime","White, Robert S","32480211"],"journal":"J Clin Anesth","authors":["Hoyler, Marguerite M","Abramovitz, Sharon","Aaronson, Jaime","White, Robert S"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32480211","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jclinane.2020.109938","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1668437835086036992,"score":9.490897,"similar":[{"pmid":32496574,"title":"Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan.","text":["Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan.","Asymptomatic transmission of SARS-CoV-2 is a major issue in healthcare settings, and management in perinatal wards requires particular caution. Located in central Tokyo as a tertiary center, Keio University Hospital implemented universal PCR testing on patients before admission starting April 6 2020, in response to a nosocomial outbreak of COVID-19. The present study reports a retrospective review of 52 obstetric patients universally tested for SARS-CoV-2 admitted to this hospital between April 6 and April 27, 2020.","Int J Gynaecol Obstet","Ochiai, Daigo","Kasuga, Yoshifumi","Iida, Miho","Ikenoue, Satoru","Tanaka, Mamoru","32496574"],"abstract":["Asymptomatic transmission of SARS-CoV-2 is a major issue in healthcare settings, and management in perinatal wards requires particular caution. Located in central Tokyo as a tertiary center, Keio University Hospital implemented universal PCR testing on patients before admission starting April 6 2020, in response to a nosocomial outbreak of COVID-19. The present study reports a retrospective review of 52 obstetric patients universally tested for SARS-CoV-2 admitted to this hospital between April 6 and April 27, 2020."],"journal":"Int J Gynaecol Obstet","authors":["Ochiai, Daigo","Kasuga, Yoshifumi","Iida, Miho","Ikenoue, Satoru","Tanaka, Mamoru"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32496574","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/ijgo.13252","keywords":["covid-19","novel coronavirus","pregnancy"],"locations":["Tokyo","Tokyo","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1668712823924981761,"score":52.74884},{"pmid":32346672,"pmcid":"PMC7187860","title":"False-Negative COVID-19 Testing: Considerations in Obstetrical Care.","text":["False-Negative COVID-19 Testing: Considerations in Obstetrical Care.","Am J Obstet Gynecol MFM","Kelly, Jeannie C","Dombrowksi, Michael","O'neil-Callahan, Micaela","Kernberg, Annessa S","Frolova, Antonina I","Stout, Molly J","32346672"],"journal":"Am J Obstet Gynecol MFM","authors":["Kelly, Jeannie C","Dombrowksi, Michael","O'neil-Callahan, Micaela","Kernberg, Annessa S","Frolova, Antonina I","Stout, Molly J"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346672","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.ajogmf.2020.100130","keywords":["covid-19","sars-cov-2","coronavirus","diagnostic test sensitivity","pregnancy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495368822784,"score":45.79572},{"pmid":32369613,"title":"Effectiveness of a COVID-19 screening questionnaire for pregnant women at admission to an obstetric unit in Milan.","text":["Effectiveness of a COVID-19 screening questionnaire for pregnant women at admission to an obstetric unit in Milan.","Sutton et al. [1] recently reported on universal testing with nasopharyngeal swabs to detect severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection in 215 women admitted for delivery at the Presbyterian Allen Hospital in New York, USA. They identified 33 (15.3%) infected women, of whom only four had fever or symptoms suggesting coronavirus disease 2019 (COVID-19). These findings suggest that only universal testing can reliably recognize infected cases. However, this approach is only feasible in major hospitals in high-resource countries with efficient lab facilities in-house. Alternative approaches deserve consideration.","Int J Gynaecol Obstet","Tassis, Beatrice","Lunghi, Giovanna","Frattaruolo, Maria Pina","Ruggiero, Marta","Somigliana, Edgardo","Ferrazzi, Enrico","32369613"],"abstract":["Sutton et al. [1] recently reported on universal testing with nasopharyngeal swabs to detect severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection in 215 women admitted for delivery at the Presbyterian Allen Hospital in New York, USA. They identified 33 (15.3%) infected women, of whom only four had fever or symptoms suggesting coronavirus disease 2019 (COVID-19). These findings suggest that only universal testing can reliably recognize infected cases. However, this approach is only feasible in major hospitals in high-resource countries with efficient lab facilities in-house. Alternative approaches deserve consideration."],"journal":"Int J Gynaecol Obstet","authors":["Tassis, Beatrice","Lunghi, Giovanna","Frattaruolo, Maria Pina","Ruggiero, Marta","Somigliana, Edgardo","Ferrazzi, Enrico"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369613","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/ijgo.13191","keywords":["covid-19","coronavirus","obstetrics unit","sars-cov-2","screening"],"locations":["New York","USA","Milan"],"countries":["United States","Italy"],"countries_codes":["USA|United States","ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496140574721,"score":45.43596},{"pmid":32301478,"title":"Counting Coronavirus Disease 2019 (COVID-19) Cases: Case Definitions, Screened Populations and Testing Techniques Matter.","text":["Counting Coronavirus Disease 2019 (COVID-19) Cases: Case Definitions, Screened Populations and Testing Techniques Matter.","While counting cases of disease appears straightforward, there are issues to consider when enumerating disease counts during an epidemic. For example, for Coronavirus Disease-2019 (COVID-19), how is a case defined? Hubei province in China changed its case definition twice in a fortnight-from laboratory-confirmed cases to clinically-confirmed cases without laboratory tests, and back to laboratory-confirmed cases. This caused confusion in the reported number of cases. If a confirmed case requires laboratory testing, what is the population who are laboratory-tested? Due to limited laboratory testing capacity in the early phase of an emerging epidemic, only \"suspected cases\" are laboratory-tested in most countries. This will result in underdiagnosis of confirmed cases and also raises the question: how is a \"suspect case\" defined? With the passage of time and increased capability to perform laboratory tests, more people can be screened and the number of confirmed cases will increase. What are the technical considerations of laboratory testing? This includes specimen collection (variable collection methods), samples collected (upper or lower respiratory tract biospecimens), time of collection in relation to course of disease, different laboratory test methods and kits (not all of which may be standardised or approved by authorities such as the Food and Drug Administration). Are approved laboratory facilities and trained manpower available, and how are test results interpreted and false-negatives excluded? These issues will affect the accuracy of disease counts, which in turn will have implications on how we mount an appropriate response to the outbreak.","Ann Acad Med Singapore","Koh, David","Cunningham, Anne Catherine","32301478"],"abstract":["While counting cases of disease appears straightforward, there are issues to consider when enumerating disease counts during an epidemic. For example, for Coronavirus Disease-2019 (COVID-19), how is a case defined? Hubei province in China changed its case definition twice in a fortnight-from laboratory-confirmed cases to clinically-confirmed cases without laboratory tests, and back to laboratory-confirmed cases. This caused confusion in the reported number of cases. If a confirmed case requires laboratory testing, what is the population who are laboratory-tested? Due to limited laboratory testing capacity in the early phase of an emerging epidemic, only \"suspected cases\" are laboratory-tested in most countries. This will result in underdiagnosis of confirmed cases and also raises the question: how is a \"suspect case\" defined? With the passage of time and increased capability to perform laboratory tests, more people can be screened and the number of confirmed cases will increase. What are the technical considerations of laboratory testing? This includes specimen collection (variable collection methods), samples collected (upper or lower respiratory tract biospecimens), time of collection in relation to course of disease, different laboratory test methods and kits (not all of which may be standardised or approved by authorities such as the Food and Drug Administration). Are approved laboratory facilities and trained manpower available, and how are test results interpreted and false-negatives excluded? These issues will affect the accuracy of disease counts, which in turn will have implications on how we mount an appropriate response to the outbreak."],"journal":"Ann Acad Med Singapore","authors":["Koh, David","Cunningham, Anne Catherine"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301478","source":"PubMed","week":"202016|Apr 13 - Apr 19","locations":["Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494852923392,"score":43.088646},{"pmid":32463477,"title":"[Serological tests should be related to the aim of the testing, as well as the population].","text":["[Serological tests should be related to the aim of the testing, as well as the population].","Expectations are high on serological tests for SARS-CoV-2. Further knowledge of the immunity is needed, but also evaluation of the reliability of the tests. Important for the latter is for which purpose the test is conducted and how common the outcome to be identified is (antibodies). For the determination of immunity at the individual level, the specificity of the test must be very high, preferably 100%. Even tests where the specificity is perceived as high, e.g. 95% or 99%, can lead to a large proportion of false positives, if the proportion of the population actually infected is small.","Lakartidningen","Modig, Karin","Gemes, Katalin","Feychting, Maria","32463477"],"abstract":["Expectations are high on serological tests for SARS-CoV-2. Further knowledge of the immunity is needed, but also evaluation of the reliability of the tests. Important for the latter is for which purpose the test is conducted and how common the outcome to be identified is (antibodies). For the determination of immunity at the individual level, the specificity of the test must be very high, preferably 100%. Even tests where the specificity is perceived as high, e.g. 95% or 99%, can lead to a large proportion of false positives, if the proportion of the population actually infected is small."],"journal":"Lakartidningen","authors":["Modig, Karin","Gemes, Katalin","Feychting, Maria"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463477","source":"PubMed","week":"202022|May 25 - May 31","topics":["Diagnosis"],"weight":1,"_version_":1668079521546371072,"score":41.025322}]}